Carenostics
Kanishka Rao has a diverse work experience, starting with their current position as Co-Founder and COO at Carenostics, a mission-driven startup focused on addressing chronic disease diagnosis, treatment, and health inequities. Prior to this, they worked at McKinsey New Ventures, where they founded and led the Healthtech Startups practice in the US, a joint-venture between Fuel by McKinsey and McKinsey's Healthcare practice. Kanishka also worked as an Engagement Manager at McKinsey & Company. Earlier in their career, Kanishka was a Summer Analyst at The Blackstone Group and a Software Development Intern at Siemens Healthcare's Innovation Center.
Kanishka Rao's education history includes a Bachelor of Science in Economics (BSEcon) degree with a focus on Management: Entrepreneurship & Innovation from The Wharton School. Kanishka also holds a Master of Science in Engineering (MSE) degree in Computer Science from the University of Pennsylvania, as well as a Bachelor of Applied Science (BASc) degree in Computer Science from the Jerome Fisher M&T Program. Prior to their higher education, Kanishka earned a High School Diploma from Conestoga Senior High School. In addition to their formal education, they obtained a Professional Scrum Master I (PSM I) certification from Scrum.org in October 2019.
This person is not in any teams
This person is not in any offices
Carenostics
Carenostics develops healthcare AI solutions to identify opportunities for earlier clinical intervention with chronic disease patients. We learn machine learning models from patient data collected in routine care, and integrate directly into provider EHRs to help physicians identify patients with undiagnosed chronic disease, project their decline over time, and match them to guideline / evidence-based treatment. Carenostics partners with leading providers, payers, pharma companies, care management companies, academics, and government agencies to address the gaps in chronic disease care. Our flagship solution, CKDx, is a clinical decision support tool developed with the goal of eradicating undiagnosed chronic kidney disease while reducing the disparities in care faced by minority populations.